Tag

Ms Progression

All articles tagged with #ms progression

"Latest MS News: EBV, DMT Discontinuation, and Treatment Updates"

Originally Published 2 years ago — by Multiple Sclerosis News Today

Featured image for "Latest MS News: EBV, DMT Discontinuation, and Treatment Updates"
Source: Multiple Sclerosis News Today

Research presented at the joint meeting of ECTRIMS and ACTRIMS suggests that a combination of faulty immune regulation, genetics, and specific strains of the Epstein-Barr virus (EBV) may increase the risk of developing MS. Stopping disease-modifying therapy (DMT) can lead to new disease activity, as shown in a study that had to be ended early due to participants experiencing increased disease activity. Encouraging treatment reports include the potential of foralumab to ease brain inflammation in secondary progressive MS, fenebrutinib's ability to reduce new inflammatory lesions in relapsing MS, and ongoing efforts to find ways to curb MS progression.

"Unveiling the Silent Progression of Multiple Sclerosis: Ignoring Treatments"

Originally Published 2 years ago — by Multiple Sclerosis News Today

Featured image for "Unveiling the Silent Progression of Multiple Sclerosis: Ignoring Treatments"
Source: Multiple Sclerosis News Today

Silent progression, also known as progression independent of relapse activity (PIRA), is a common phenomenon in multiple sclerosis (MS) where disability worsens without experiencing relapses. A review of studies suggests that PIRA accounts for at least 50% of reported instances of disability worsening in people with relapsing-remitting MS. Additionally, factors such as medication side effects, cost, and the form of treatment (injections, infusions, or pills) can influence MS patients' adherence to their treatments. The author questions the labeling of MS stages and emphasizes the importance of considering cost when making treatment decisions.